Role of the Estrogen and Progestin in Hormonal Replacement Therapy on Apolipoprotein A-I Kinetics in Postmenopausal Women

S. Lamon-Fava, B. Postfai, M. Diffenderfer, C. Deluca, J. O'Connor, F.K. Welty, G.G. Dolnikowski, Hugh Barrett, E.J. Schaefer

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    Objective - Plasma high-density lipoprotein (HDL) cholesterol levels are inversely correlated with the risk of developing coronary heart disease. Hormonal replacement therapy (HRT) affects plasma HDL cholesterol levels, with estrogen increasing HDL cholesterol levels and progestins blunting this effect. This study was designed to assess the mechanism responsible for these effects.Materials and Methods - HDL apolipoprotein A-I (apoA-I) kinetics were studied in 8 healthy postmenopausal women participating in a double-blind, randomized, crossover study comprising 3 phases: placebo, conjugated equine estrogen (CEE) (0.625 mg/d), and CEE plus medroxyprogesterone acetate (MPA) (2.5 mg/d). Compared with placebo, treatment with CEE resulted in an increase in apoA-I pool size ( + 20%, P < 0.01) because of a significant increase in apoA-I production rate ( + 47%, P < 0.05) and no significant changes in apoA-I fractional catabolic rate. Compared with the CEE alone phase, treatment with the CEE plus MPA resulted in an 8% (P < 0.02) reduction in apoA-I pool size and a significant reduction in apoA-I production rate ( - 13%, P < 0.04), without changes in apoA-I fractional catabolic rate.Conclusion - Postmenopausal estrogen replacement increases apoA-I levels and production rate. When progestin is added to estrogen, it opposes these effects by reducing the production of apoA-I.
    Original languageEnglish
    Pages (from-to)385-391
    JournalArterioslcerosis, Thrombosis, and Vascular Biology
    Volume26
    Issue number2
    DOIs
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'Role of the Estrogen and Progestin in Hormonal Replacement Therapy on Apolipoprotein A-I Kinetics in Postmenopausal Women'. Together they form a unique fingerprint.

    Cite this